XGN is currently covered by 7 analysts with an average price target of $9.38. This is a potential upside of $5.61 (148.81%) from yesterday's end of day stock price of $3.77.
Exagen's activity chart (see below) currently has 59 price targets and 69 ratings on display. The stock rating distribution of XGN is 100% BUY.
Analysts' price targets on this stock were met 39.83% of the time, taking 101.71 days on average.
Highest price target for XGN is $12, Lowest price target is $8, average price target is $9.38.
Most recent stock forecast was given by KYLE MIKSON from CANACCORD. First documented stock forecast 14-Oct-2019.
Currently out of the existing stock ratings of XGN, 17 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 01-Jun-2020
$9
$4.87 (117.92%)
$11
6 days ago
(11-Nov-2026)
Buy Since 07-Oct-2020
$9
$4.87 (117.92%)
$9
6 days ago
(11-Nov-2026)
Buy Since 21-Jul-2025
$10
$5.87 (142.13%)
$10
3 months 12 days ago
(05-Aug-2026)
2/4 (50%)
$3.35 (50.38%)
52
Buy Since 11-Sep-2025
$12
$7.87 (190.56%)
3 months 12 days ago
(05-Aug-2026)
0/2 (0%)
$5.35 (80.45%)
Buy Since 15-Apr-2021
$8
$3.87 (93.70%)
$16
4 months 23 days ago
(25-Jun-2026)
1/4 (25%)
$3.36 (72.41%)
85
What is XGN (Exagen) average time for price targets to be met?
Which analyst most recently updated their price target on XGN (Exagen)?
Which analyst has the most public recommendations on XGN (Exagen)?
Which analyst is the currently most bullish on XGN (Exagen)?
Which analyst is the currently most reserved on XGN (Exagen)?